Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Sep 24, 2026
Reporting period
Not applicable
Filed with the SEC
Sep 25, 2026
CEOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001628280-26-063576
Filed / recorded
Sep 25, 2026, 8:12 PM UTC
Added to OQRO
Oct 7, 2026, 1:53 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Strata Critical Medical, Inc.
Issuer CIK
1779128
Ticker
SRTA
Reporting person
William A. Heyburn
Relationship
Director, Officer
Officer title
Co-CEO and CFO
Security
Class A common stock, $0.0001 par value per share
Table
Non-derivative (Table I)
Transaction date
Sep 24, 2026
Transaction code
A
Shares / units
177,858
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
1,856,206
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on August 29. 2025.
Around the same time
The Eric L. Affeldt Living Trust DTD 2/14/2005Insider
A Strata Critical Medical insider told the SEC about a plan to sell $517K of Strata Critical Medical shares around Oct 2, 2026. The shares were not acquired as compensation. That is 0.1% of all Strata Critical Medical shares.